Results for tag: "Firmagon"

Firmagon is a type of prostate cancer drug used to treat advanced stages of the disease. It is a hormone therapy drug, which works by blocking the production of testosterone, a hormone that can fuel the growth of prostate cancer cells. Firmagon is administered as an injection, and is typically used in combination with other treatments such as radiation therapy or chemotherapy. It is also used to reduce the risk of cancer recurrence after surgery. Firmagon is a relatively new drug, having been approved by the US Food and Drug Administration in 2012. It is currently the only approved drug of its kind, and is used to treat advanced prostate cancer in men who have not responded to other treatments. The Firmagon market is composed of a number of companies that produce and distribute the drug. These include Novartis, Sanofi, Pfizer, and Astellas Pharma. Additionally, there are a number of generic versions of Firmagon available, produced by companies such as Mylan and Teva Pharmaceuticals. Show Less Read more